ALGS
NASDAQ · Biotechnology
Aligos Therapeutics Inc
$5.77
+0.34 (+6.26%)
Open$5.38
Previous Close$5.43
Day High$5.85
Day Low$5.32
52W High$13.69
52W Low$4.80
Volume—
Avg Volume71.2K
Market Cap34.47M
P/E Ratio—
EPS$-8.70
SectorBiotechnology
Analyst Ratings
Strong Buy
13 analysts
Price Target
+7.3% upside
Current
$5.77
$5.77
Target
$6.19
$6.19
$4.22
$6.19 avg
$8.57
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 1.37M | 2.54M | 10.09M |
| Net Income | -15,145,676 | -25,261,505 | -1,613,644 |
| Profit Margin | -1,106.7% | -1,051.4% | -16.0% |
| EBITDA | -54,498,443 | -95,947,963 | -2,029,249 |
| Free Cash Flow | — | — | -1,586,727 |
| Rev Growth | -46.0% | -46.0% | -9.4% |
| Debt/Equity | 0.00 | 0.00 | 0.13 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $251.64 | -1.05% | 118.2 | 429.58B |
| AMGN | Amgen Inc | $362.12 | +0.44% | 24.8 | 193.10B |
| GILD | Gilead Sciences Inc | $126.34 | +0.01% | 17.1 | 157.21B |
| VRTX | Vertex Pharmaceuticals Inc | $496.73 | -0.58% | 28.1 | 121.87B |
| REGN | Regeneron Pharmaceuticals | $623.54 | -1.31% | 15.0 | 66.35B |
| ALNY | Alnylam Pharmaceuticals Inc | $301.03 | +2.56% | 69.3 | 39.97B |